The non-Hodgkin lymphoma therapeutics market was valued at USD 9221.19 Million in 2022 and is expected to grow at a strong CAGR of around 7.7% during the forecast period (2023-2030) owing to rising number of clinical trials. https://univdatos.com/reports/non-hodgkin-lymphoma-therapeutics-market